Sara Crawford
Nurse Practitioner · Brookline, MANPI 1033758503
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $752 and has fallen 82.0% since, to $135 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $30.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$403
- AbbVie$359
- Incyte Corporation$299
- Sanofi$176
- Regeneron Healthcare Solutions, Inc.$146
- Johnson & Johnson$121
- plus $676 from 14 others
What the payments were for
- Food & beverage$2,181100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 11 | $403 |
| AbbVie | 12 | $359 |
| Incyte Corporation | 11 | $299 |
| Sanofi | 3 | $176 |
| Regeneron Healthcare Solutions, Inc. | 6 | $146 |
| Johnson & Johnson | 5 | $121 |
| AstraZeneca | 1 | $120 |
| Novartis | 4 | $103 |
| Amgen | 2 | $65 |
| Dermavant Sciences, Inc. | 1 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $50 |
| Galderma Laboratories, L.p. | 3 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Strata Skin Sciences, Inc. | 2 | $36 |
| Pfizer | 1 | $29 |
| UCB, Inc. | 1 | $28 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| Smith+Nephew | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,181 in reported general payments places this provider in the 95th percentile of 3,855 nurse practitioner providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 21 | $516 |
| Doxycycline Monohydrate | 17 | $366 |
| Triamcinolone Acetonide | 19 | $99 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Brookline
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
- Lauren BurkeBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.